Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects

Faludi, André Arpad; Aldrighi, José Mendes; Bertolami, Marcelo Chiara; Saleh, Mohamed H; Silva, Renata Alves; Nakamura, Yara; Pereira, Isabela RO; Abdalla, Dulcineia Saes Parra; Ramires, José Antonio Franchini; Jose Eduardo MR Sousa.
Atherosclerosis ; 177(01): 89-96, nov 2004.
Artículo en Inglés | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1060106

Documentos relacionados

  1. Hormone replacement therapy - where are we now?
  2. Hormone Replacement Therapy and Psoriasis Risk: A Nationwide Population-Based Cohort Study.
  3. Menopausal Hormone Therapy and Health Outcomes: Is Timing Everything?
  4. Pelvic Images of 46,XX Pure Gonadal Dysgenesis Patient after Hormone Replacement Therapy.
  5. Prescription rules of hormone replacement therapy and its alternative.
  6. The effect of hormone replacement therapy on cognition and mood.
  7. [The 2023 Chinese menopause symptom management and menopausal hormone therapy guidelines].
  8. The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results data.
  9. Reply to The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results data.
  10. ALTERNATIVES OF MENOPAUSAL HORMONE THERAPY.